You are here:
People from around the world will mark World Pneumonia Day on 12 November.
More than 1.5 million children die every year from pneumonia, more than from any other disease. But a million children’s lives a year could be saved by simple interventions such as vaccination against the most common causes of pneumonia and treatment with antibiotics.
For the first time in history, thanks to the GAVI Alliance partners, vaccines against the leading cause of pneumonia are reaching children in developing countries at nearly the same time they reach children in high income countries. This is unprecedented. The introduction of these vaccines is a cornerstone of GAVI’s ambitious plan to ensure that all children have equal access to life-saving vaccines.
The GAVI Alliance is a founder member of the Global Coalition against Child Pneumonia, formed in 2009 to raise awareness and to encourage governments to support the implementation of a range of proven measures to prevent and treat pneumonia.
Watch the latest installment in the World Pneumonia Day video series, and the essential part that childhood vaccination can play in combatting pneumonia.Learn more from pneumonia and pneumococcal vaccine experts
Photo galleries from the rollout of pneumococcal vaccines in Kenya and Yemen
Access and download high-resolution images from the rollout of pneumococcal vaccines
Join the Blog Carnival!
15 NovPneumonia: No friend of mine - Seth Berkley, CEO of the GAVI Alliance
12 NovPneumococcal vaccine is saving lives already - Mwai Kibaki, President of the republic of Kenya
12 NovShot in arm breathes hope into lives of world's most vulnerable (The Age) - Sir Gus Nossal, former President of International Union of Immunological Societies, former Chair of WHO's expert advisory group on vaccines
12 NovFighting pneumonia in Bangladesh (ONE.org) - UK Parliamentarian Jim Dobbin, MP
9 NovThe WPD Generation: Moving the needle to fight childhood disease (ONE.org) - Bill Roedy, former CEO of MTV, GAVI Envoy
9 NovPneumonia takes the lives of millions of babies…vaccinate! (Results.org) - Kate O'Brien, Deputy Director, International Vaccine Access Center (IVAC)
9 NovRwanda is Proud to Pioneer the Pneumococcal Vaccine (ONE.org) - Agnes Binagwaho, Rwanda’s minister of health
8 Nov'No child should die of a disease we can prevent' (ONE.org) - Joseph Yieleh Chireh, Ghana’s minister of health
8 Nov Pour lutter contre la pneumonie – vaccinez vos enfants ! - Guy Aho Tete Benissan Coordinateur régional du REPAOC, membre du Comité de pilotage du Forum des OSC partenaires de GAVI Alliance
View more blogs...
Source: WHO-UNICEF coverage estimates for 1980-2010, as of July 2011. Coverage projections for 2011-2012, as of September 2011. World Population Prospects, the 2010 revision. New York, United Nations, 2010 (surviving infants).
With GAVI’s support, the roll-out of the pneumococcal vaccines in developing countries began in Nicaragua in December 2010. In 2011 alone, 15 more countries have introduced pneumococcal vaccines into their national routine immunisation programmes. See the timeline.
In September 2011, a total of 37 countries have been approved for GAVI support to introduce pneumococcal conjugate vaccine. Of these 37 countries, 18 countries were approved for 2012. This is an unprecedented ramp up.
Pneumococcal vaccines will soon be administered in more than half of GAVI eligible countries. However millions of children still do not have access to the vaccine. GAVI is working to vaccinate 90 million children in 58 countries against pneumococcal disease by 2015. This plan will be a major contribution to MDG 4 - to decrease childhood deaths by two-thirds by 2015 – that can only be achieved by an intensified effort to reduce pneumonia deaths.
11 November 2012
World Pneumonia Day 2012
World Pneumonia Day aims to raise awareness about the leading cause of under five child deaths in developing countries, and what can be done to fight this deadly disease.
05 July 2012
Accelerated Vaccine Introduction Project review: final report
This report presents the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project undertaken by Cambridge Economic Policy Associates (CEPA) for the GAVI Alliance. The review period spans from February to June 2012.
Accelerated Vaccine Introduction Project review: annexes
Annexes to report presenting the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project. The review period spans from February to June 2012.
01 June 2012
2012 Pneumococcal AMC Annual Report
The 2012 Pneumococcal AMC Annual Report gives an overview of all activities linked to the implementation of the pilot Advance Market Commitment from 1 April 2011 to 31 March 2012. It provides an extensive description of the first achievements of this innovative initiative: the first introductions of pneumococcal vaccines in GAVI countries.
12 November 2011
Pneumococcal vaccines introduced in Malawi
On 12 November 2011, World Pnuemonia Day, Malawi became the 16th GAVI-eligible country to introduce the pneumococcal vaccine, protecting children in the country against the leading cause of pneumonia.
The pneumococcal Advance Market Commitment (AMC) is an innovative way to make effective and affordable pneumococcal vaccines available for children in developing countries.
Through donor commitments, this innovative funding mechanism incentivises vaccine makers to produce suitable and affordable vaccines for the world's poorest countries. These countries are then able to plan for immunisation programmes knowing that vaccines will be available rapidly.
Pneumococcal factsheet - GAVI support for pneumococcal vaccines
Infographic - The challenges and promise of the fight against
Five Things You Can Do - Easy
steps to get involved.
Visit the World Pneumonia Day website for more resources from their Activist Toolkit, including: Event planning and online tools.
© GAVI Alliance 2014
modal window here